A 12 Week, Randomized, Double-blind, Placebo-controlled, Phase II Trial to Evaluate the Efficacy and Safety of the Treatment With BPL-1 in Adult Patients With Type 2 Diabetes Mellitus With Different Course of Disease and Treatment

Author(s):  
2014 ◽  
Vol 31 (6) ◽  
pp. 621-638 ◽  
Author(s):  
Takashi Kadowaki ◽  
Masakazu Haneda ◽  
Nobuya Inagaki ◽  
Yasuo Terauchi ◽  
Atsushi Taniguchi ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document